Related Experiment Video
Updated: May 6, 2026

06:55
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.3K
Validation of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Coding in US Claims Data
Joshua U Okonkwo1,2, Erika K Williams1,2, Reza Sadjadi1,2
1Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Pharmacoepidemiology and Drug Safety
|March 3, 2025
Summary
Validating Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) diagnosis codes in claims data is crucial. Requiring two CIDP codes improves the accuracy of identifying actual CIDP cases in patient cohorts.
Area of Science:
- Neurology
- Clinical Epidemiology
- Health Informatics
Background:
- Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare autoimmune disorder affecting the peripheral nervous system.
- The accuracy of using administrative claims data for identifying CIDP cases is not well-established.
- Accurate case identification is essential for research and healthcare management.
Purpose of the Study:
- To validate the performance of claims-based algorithms for identifying CIDP cases.
- To assess the positive predictive value (PPV) of diagnosis codes and intravenous immunoglobulin (IVIG) use in claims data.
- To compare the accuracy of different algorithm configurations.
Main Methods:
- A validation study was conducted using linked electronic health record and Medicare claims data (2008-2020).
- Claims-based algorithms required specific International Classification of Diseases (ICD-9/10) CIDP codes prior to IVIG use.
- Chart review by neurologists served as the reference standard for CIDP diagnosis.
Main Results:
- The PPV of an algorithm requiring at least one CIDP code before IVIG was 66.2%.
- Requiring at least two CIDP codes increased the PPV to 71.2%.
- The PPV for patients meeting specific European diagnostic criteria was lower at 30.0%.
Conclusions:
- Claims-based algorithms identify a significant proportion of patients with other chronic inflammatory neuropathies, not strictly CIDP.
- Increasing the number of required CIDP codes enhances the PPV of claims-based case identification.
- Refined algorithms are needed for more precise identification of CIDP in large datasets.

